Webinar Series: Perspectives on US Cost-Effectiveness Thresholds

07/29/2019

---

Striking a ‘Grand Bargain’ for a PCSK9 Inhibitor

05/02/2018

---

Health Affairs: Policy Strategies For Aligning Price And Value For Brand-Name Pharmaceuticals.

03/16/2018

---

New and Noteworthy in November

11/01/2017

---

New and Noteworthy in October

09/28/2017

---

New and Noteworthy in September

09/01/2017

---

ICER Addresses Misrepresentation of its Methods

08/10/2017

---

New and Noteworthy in July

06/30/2017

---

ICER’s Drug Pricing Work Featured in Wired

06/14/2017

---

New and Noteworthy in June

06/01/2017

---